研究:皮层内微刺激在人体中实现长达 10 年的安全触觉反馈
Long-term safety and efficacy of intracortical microstimulation in humans
一项发表于 NCT01894802 早期可行性临床试验的研究评估了皮层内微刺激(ICMS)的长期安全性、有效性与持久性。5 名脊髓损伤受试者各植入两个 Blackrock NeuroPort 微电极阵列,累计植入时长 27 年、植入时间跨度 2 至 10 年,共施加超过 1.68 亿次 ICMS 脉冲,未出现严重不良事件,也未对电极健康造成直接负面影响。
5 名受试者、累计 27 年植入时长与 1.68 亿次刺激脉冲,为皮层内微刺激恢复触觉的长期安全性提供了人体数据。
Abstract:
Intracortical microstimulation (ICMS) of somatosensory cortex can restore a sense of touch to people with spinal cord injury. In this early feasibility clinical trial (NCT01894802), we evaluated the safety, efficacy, and longevity of ICMS because there is a paucity of such long-term studies in humans. This information is crucial to the development of clinical neuromodulation devices, particularly for restoring touch, hearing, and vision. ICMS was delivered to five participants with spinal cord injury who were each implanted with two Blackrock NeuroPort microelectrode arrays in the hand representation of Brodmann’s area 1. Across implant durations spanning 2 to 10 years, we measured single-electrode detection thresholds, projected fields, quality reports, and electrode health characteristics. ICMS-related adverse events were documented throughout. More than 168 million ICMS pulses were delivered across a combined implant duration of 27 years without any serious adverse events or direct negative effects on electrode health. ICMS consistently evoked sensations localized to the hand. Rarely, sensations persisted for brief periods after stimulation offset (3 to 25 events across participants). ICMS detection thresholds increased slowly over time (about 3.5 microamperes per year), but 64 ± 13% of the electrodes still reliably evoked tactile sensations (about 21% decrease in functional electrodes), including 60% of the electrodes after 10 years in one participant. The quality and projected field coverage of ICMS-evoked sensations were both consistent. Delivering ICMS to the somatosensory cortex was safe and effective, consistently evoking informative somatosensory percepts as long as 10 years, demonstrating the clinical promise of ICMS for sensory restoration.
Authors:
Charles M. Greenspon; Taylor G. Hobbs , Ceci Verbaarschot , Ali H. Alamri , Natalya D. Shelchkova , Robin Lienkämper, Joel Ye, Tyler W. Simpson, Jeffrey M. Weiss, David M. Weir, Debbie E. Harrington, Ashley Van Driesche, David Satzer, Giacomo Valle, Lee E. Miller, Nicholas G. Hatsopoulos, Jorge Gonzalez-Martinez, Peter C. Warnke, John E. Downey, Michael L. Boninger, Jennifer L. Collinger, and Robert A. Gaunt
Read the full paper here.
来源:Blackrock Neurotech · blackrockneurotech.com